Synergistic Arrythmia Origin Identification System

A comprehensive system integrating cardiac mapping, AI, IoT, blockchain, and new materials to accurately identify and track arrythmia origins, enabling personalized treatment and real-time monitoring.

The original patent, 'Finding the origin of an arrythmia,' addresses the challenge of locating the source of cardiac arrythmias. However, it relies on invasive procedures and lacks integration with emerging technologies. The new inventive concept resolves this limitation by synergistically combining distinct technologies to create a more powerful, accurate, and efficient system for arrythmia origin identification.

The Synergistic Arrythmia Origin Identification System comprises multiple modules: 1) a cardiac mapping module, which generates a 3D map of the heart chamber; 2) an AI-powered arrythmia detection module, utilizing machine learning algorithms to analyze local activation times (LATs) and identify potential arrythmia origins; 3) an IoT-enabled sensor module, which measures LATs and transmits data securely using blockchain technology; 4) a visualization module, displaying the identified origin on a 3D map; 5) a wearable device with an integrated ECG sensor and AI-powered arrythmia detection module for real-time monitoring; and 6) a cloud-based data storage module utilizing blockchain technology for secure data transmission. The system also enables personalized treatment by generating 3D-printed models of heart chambers using new materials and applying targeted ablation therapy to the identified origin.

The new claims introduce a synergistic combination of AI, IoT, blockchain, and new materials, which significantly enhances the accuracy and efficiency of arrythmia origin identification. This integration of distinct technologies provides a novel and non-obvious solution compared to the original patent.

Alternative embodiments of the inventive concept could include: 1) integrating the system with existing medical devices, such as pacemakers or implantable cardioverter-defibrillators; 2) using different machine learning algorithms or AI models for arrythmia detection; 3) incorporating additional sensors or data sources, such as blood pressure or oxygen saturation monitors; and 4) developing miniaturized or implantable versions of the wearable device.

The Synergistic Arrythmia Origin Identification System has significant commercial potential in the medical device and healthcare industries, particularly in the areas of cardiac arrythmia treatment, personalized medicine, and remote patient monitoring. The system could be marketed to hospitals, clinics, and medical research institutions, with potential for widespread adoption and revenue growth.